tag:www.gov.uk,2005:/government/organisations/advisory-council-on-the-misuse-of-drugs Advisory Council on the Misuse of Drugs - Activity on °Ç¸ç³Ô¹Ï HM Government 2026-05-13T12:00:07Z /government/publications/drug-use-in-ethnic-minority-groups-a-review-and-recommendations#2026-05-13T12:00:07Z 2026-05-13T12:00:07Z Research: Drug use in ethnic minority groups: a review and recommendations This report reviews drug use in ethnic minority groups and outlines recommendations for further data collection. /government/publications/semi-synthetic-cannabinoids-related-to-tetrahydro-cannabinol-and-cannabidiol#2026-05-11T11:00:02Z 2026-05-11T11:00:02Z Independent report: Semi-synthetic cannabinoids related to tetrahydro-cannabinol and cannabidiol ACMD review into the use and harms of SSCs and THCA to identify compounds causing harm which are not captured by the current generic definition for cannabinoids. /government/publications/acmd-annual-report-2023-to-2025#2026-05-08T15:52:19Z 2026-05-08T15:52:19Z Corporate report: ACMD annual report 2023 to 2025 An overview of work carried out by the Advisory Council on the Misuse of Drugs (ACMD) from January 2023 to December 2025. /government/publications/acmd-advice-on-2-benzyl-benzimidazole-and-piperidine-benzimidazolone-opioids#2026-04-30T11:36:48Z 2026-04-30T11:36:48Z Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids. /government/publications/ethylbromazolam-review-of-the-evidence-on-its-use-and-harms#2026-04-14T11:00:01Z 2026-04-14T11:00:01Z Research: Ethylbromazolam: review of the evidence on its use and harms The report reviews the evidence on the use and harms of the novel benzodiazepine ethylbromazolam and recommends control under the Misuse of Drugs Act 1971. /government/publications/members-register-of-interests#2026-03-23T16:12:00Z 2026-03-23T16:12:00Z Corporate report: ACMD members' register of interests Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD). /government/publications/acmd-work-programme-2026#2026-03-11T09:00:01Z 2026-03-11T09:00:01Z Correspondence: ACMD work programme 2026 Letter to the the Minister for Policing and Crime from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2026. /government/publications/government-response-to-3-medicines-reports#2026-02-23T12:00:03Z 2026-02-23T12:00:03Z Correspondence: Government response to 3 medicines reports This response agrees with recommendations from the Advisory Council on the Misuse of Drugs (ACMD) in 3 reports about the control and scheduling of 5 medicines. /government/publications/ganaxolone-acmd-advice#2026-02-23T12:00:03Z 2026-02-23T12:00:03Z Correspondence: Ganaxolone: ACMD advice Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone. /government/publications/zuranolone-acmd-advice#2026-02-23T12:00:03Z 2026-02-23T12:00:03Z Correspondence: Zuranolone: ACMD advice Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone. /government/publications/somapacitan-lonapegsomatropin-and-somatrogon-acmd-advice#2026-02-23T12:00:03Z 2026-02-23T12:00:03Z Correspondence: Somapacitan, lonapegsomatropin and somatrogon: ACMD advice Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about 3 growth hormone agonists. /government/publications/acmd-review-of-the-evidence-on-the-use-and-harms-of-etomidate#2026-02-06T09:04:40Z 2026-02-06T09:04:40Z Independent report: ACMD review of the evidence on the use and harms of etomidate The report presents a review of etomidate and structurally related compounds and subsequent recommendations regarding their classification and scheduling. /government/publications/carisoprodol-review-of-the-evidence-on-its-use-and-harms#2026-02-05T00:01:04Z 2026-02-05T00:01:04Z Research: Carisoprodol: review of the evidence on its use and harms This report considers the use, harms and control of carisoprodol, a muscle relaxant previously prescribed in the UK to treat muscle spasms. /government/news/new-members-appointed-to-acmd#2026-02-03T12:35:48Z 2026-02-03T12:35:48Z New members appointed to ACMD Two leading experts have been appointed as members of the Advisory Council on the Misuse of Drugs. /government/publications/advisory-council-on-the-misuse-of-drugs-member-biographies#2026-02-02T09:00:07Z 2026-02-02T09:00:07Z Transparency data: Advisory Council on the Misuse of Drugs member biographies Biographies of members of the Advisory Council on the Misuse of Drugs. /government/publications/ketamine-an-updated-review-of-use-and-harms#2026-01-28T13:28:01Z 2026-01-28T13:28:01Z Research: Ketamine: an updated review of use and harms Following a 2025 government commission, the ACMD has carried out a review of the use and harms of ketamine. /government/news/acmd-announces-decision-on-the-classification-of-ketamine#2026-01-28T11:03:17Z 2026-01-28T11:03:17Z ACMD announces decision on the classification of ketamine The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine. /government/publications/use-and-harms-of-xylazine-medetomidine-and-detomidine#2026-01-16T11:21:26Z 2026-01-16T11:21:26Z Research: Use and harms of xylazine, medetomidine and detomidine Review of the evidence on the use and harms of xylazine, medetomidine and detomidine. /government/calls-for-evidence/drug-use-in-lgbt-communities-and-chemsex#2025-12-05T12:00:00Z 2025-12-05T12:00:00Z Drug use in LGBT+ communities and chemsex The Advisory Council on the Misuse of Drugs (ACMD) is reviewing the evidence of drug use in LGBT+ communities and in the context of chemsex in the UK. /government/news/david-wood-to-chair-advisory-council-on-the-misuse-of-drugs#2025-12-03T11:02:18Z 2025-12-03T11:02:18Z David Wood to chair Advisory Council on the Misuse of Drugs Professor Wood will replace Owen Bowden-Jones as chair on 1 January 2026.